+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective

Scandinavian Journal of Gastroenterology 45(11): 1345-1349

Colorectal cancer (CRC) screening programs can decide upon the type of fecal occult blood test (FOBT): the guaiac FOBT (g-FOBT) or the immunological FOBT (i-FOBT). The effectiveness of any screening program depends not only on the diagnostic performance of the screening test but also on the compliance and general acceptance of the test by the public. Any decision on the type of FOBT for CRC screening should also take acceptation and perception into account. The aim of the present study was to study differences in patient perception between i-FOBT and g-FOBT and differences in perception and participation rates among relevant subgroups in a population based study. Differences in patient perception of i-FOBT and g-FOBT and differences in perception and participation rates among relevant subgroups were investigated (n = 20,623) by sending a short questionnaire to all invited to the first Dutch CRC screening trial. i-FOBT was perceived significantly more favorable than g-FOBT. About 1275 (32%) participants reported the g-FOBT not easy to use, not easy to perform, disgusting or shameful compared to 742 (16%) for the i-FOBT (p < 0.001). The participation rate was significantly higher in those who received i-FOBT compared to the g-FOBT group: 6159 of 10,322 (60%) versus 4839 of 10,301 (47%) (p < 0.001). These findings support the selection of i-FOBT as the more appropriate test for population screening programs.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052235216

Download citation: RISBibTeXText

PMID: 20560814

DOI: 10.3109/00365521.2010.497937

Related references

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135(1): 82-90, 2008

Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. British Journal of Surgery 81(3): 448-451, 1994

Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Canadian Journal of Gastroenterology 26(3): 131-147, 2012

Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Preventive Medicine 50(5-6): 297-299, 2010

Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Digestive Diseases and Sciences 42(10): 2064-2071, 1997

From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening. Gastroenterology Nursing 28(2): 90-96, 2005

Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis. International Journal of Cancer 128(8): 1908-1917, 2011

Su1215 Systematic Review and Bivariate/Hsroc Meta-Analysis of Immunochemical and Guaiac Fecal Occult Blood Tests for Colorectal Cancer Screening. Gastroenterology 146(5): S-404, 2014

Rehydration of guaiac-based faecal occult blood tests in mass screening for colorectal cancer. An economic perspective. Scandinavian Journal of Gastroenterology 26(2): 215-218, 1991

Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer. European Journal of Cancer 48(16): 2969-2976, 2012

Modern fecal occult blood tests improve sensitivity of colorectal cancer screening while combined immunochemical and guaiac-based tests improve specificity. Evidence-Based Oncology 1(4): 105-106, 2000

Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. European Journal of Gastroenterology and Hepatology 26(9): 978-989, 2014

Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?. Gastroenterologia Y Hepatologia 32(8): 565-576, 2009

M1013 a Cost-Effectiveness Analysis in Colorectal Cancer Screening Comparing Immunochemical Faecal Occult Blood Tests with Guaiac Faecal Occult Blood Tests and No Screening. Gastroenterology 136(5): A-331, 2009

Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. Bmc Cancer 15: 705, 2015